Mindcure’s Kelsey Ramsden: Despite Market Slump, ‘Everything Is Moving In The Right Direction’ For Psychedelics Jan 25, 2022
Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share… Dec 15, 2021
With 3 Granted Patents and 41 Pending, Small Pharma Is On Track To Be One Of Europe’s Biggest Psychedelic Companies Nov 19, 2021
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine Nov 5, 2021
atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative Mental Health… Oct 19, 2021